Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Bromo-5-hydroxypyridine | HCID 2762865 | — |
| Reactant | 2-(Tributylstannyl)-1,3-thiazole | HCID 2763259 | — |
| Reactant | 2,3-Dihydro-1,2-oxazole | HCID 19350417 | — |
| Catalyst | HCID 178418397 | HCID 178418397 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | Thiazole | HCID 9256 | — |
| Product | 3-(Pyridin-3-yloxy)-4,5-dihydroisoxazole | HCID 66818532 | — |
Reaction Steps
3-(pyridin-3-yloxy)-4,5-dihydroisoxazole I-162a and I-162b were prepared according to the following procedure: Racemic dihydroisoxazole I-161 was prepared in 1 step from compound I-14 and 6-bromopyridin-3-ol using Method 5. Compound I-161 placed in a microwave vial and then dissolved in dioxane (0.02 M). 2-(tributylstannyl)thiazole and palladium tetrakis were added and the reaction was purged with Argon. At this point the reaction was heated in the microwave reactor for 20 min after which there was no starting material by TLC analysis. The mixture is concentrated and purified by flash silica gel chromatography (hexanes/ethyl acetate) to provide the desired racemic thiazole I-162 in 50% yield. These compounds can be separated using chiral HPLC methods known in the art. For example, see chiral HPLC Method disclosed herein. [M−H]−=407.3 m/z. Activity: A
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09149465B2 |
|---|
| Source dataset | uspto-grants-2015_10 |
|---|
| ORD ID | ord-07360885a76f4d7e9592a7094c958e0a |
|---|
| Source note | uspto-grants-2015_10 |
|---|